A prospective, observational study of rivaroxaban for stroke prevention in atrial fibrillation: the XANAP Korea

A prospective, observational study of rivaroxaban for stroke prevention in atrial fibrillation: the XANAP Korea

Background/Aims Atrial fibrillation (AF)-related stroke accounts for 20% of ischemic strokes. Rivaroxaban use in AF patients for preventing stroke and systemic embolism was approved in 2013 in Korea. This study was to investigate the safety and effectiveness of rivaroxaban use in Korean patients wit...

Full description

Bibliographic Details
Main Authors: Jaemin Shim, Young Keun On, Sun U. Kwon, Gi-Byoung Nam, Moon-Hyoung Lee, Hyung-Wook Park, Keun-Sik Hong, Nam-Ho Kim, Pierre Amarenco, Seung-Woon Rha, Dong-Gu Shin, Joung-Ho Rha, Young-Hoon Kim
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2021-07-01
Series:The Korean Journal of Internal Medicine
Subjects:
atrial fibrillation
korea
rivaroxaban
stroke
Online Access:http://www.kjim.org/upload/pdf/kjim-2020-217.pdf

Internet

http://www.kjim.org/upload/pdf/kjim-2020-217.pdf

Similar Items